Vivos Therapeutics Inc

NASDAQ:VVOS   3:33:28 PM EDT
3.66
+0.13 (+3.68%)
Earnings Announcements

Vivos Therapeutics Reports Fourth Quarter And Full Year 2020 Financial Results And Operational Update

Published: 03/25/2021 20:22 GMT
Vivos Therapeutics Inc (VVOS) - Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update.
Q4 Revenue $3.3 Million Versus $3.1 Million.
Cash and Cash Equivalents Were $18.2 Million at December 31, 2020.
Revenue is expected to be $4.5 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $5.05 Million
Next Quarter EPS Guidance is expected to be -$0.20

More details on our Analysts Page.